TITLE

Reduced Expression of von Hippel-Lindau Protein Correlates with Decreased Apoptosis and High Chondrosarcoma Grade

AUTHOR(S)
Changbao Chen; Hua Zhou; Xiaoguang Liu; Zhongjun Liu; Qingjun Ma
PUB. DATE
October 2011
SOURCE
Journal of Bone & Joint Surgery, American Volume;10/5/2011, Vol. 93-A Issue 19, p1833
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Mutations and loss of the von Hippel-Lindau (VHL) tumor suppressor gene are associated with most renal cancers as well as several other types of human tumors, but the potential role of the VHL protein (pVHL) in patients with chondrosarcoma has not been characterized. The purpose of the present study was to investigate the expression profiles of pVHL in chondrosarcoma and its association with clinicopathologic parameters, Bax expression, the apoptosis index, and overall survival of patients with chondrosarcoma. Methods: The messenger RNA (mRNA) and protein levels of VHL in fresh specimens from eight chondrosarcomas were studied with use of real-time polymerase chain reaction and Western blot, respectively. The protein expression of VHL and Bax was investigated by means of immunohistochemical analysis of paraffin-embedded clinical specimens from seventeen benign cartilage tumors and thirty-four chondrosarcomas. The apoptosis index in chondrosarcoma was examined by means of the TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling) assay. Curves for overall survival were drawn according to the Kaplan-Meier method, and differences were analyzed with the log-rank test. The association of pVHL expression with the clinicopathologic parameters, Bax expression, apoptosis index, and overall survival for patients with chondrosarcoma was also analyzed. Results: Levels of VHL protein (p = 0.005) and mRNA (p = 0.008) were significantly reduced in chondrosarcoma tissues as compared with the paired adjacent normal tissues. Immunohistochemical analysis showed decreased pVHL in a significantly higher proportion of chondrosarcomas (64.7%) than benign cartilage tumors (29.4%). pVHL expression was positively correlated with Bax expression and the apoptosis index in chondrosarcoma. Longitudinal studies of a cohort of patients with chondrosarcomas showed that decreased pVHL expression significantly correlated with increased tumor grade (p = 0.026) but was not independently predictive of overall survival. Conclusions: Reduced pVHL expression was associated with decreased apoptosis and increasing chondrosarcoma grade, but the relationship between these findings and chondrosarcoma pathogenesis requires further study. Clinical Relevance: Restored VHL expression could be a potential targeted therapy to treat chondrosarcoma.
ACCESSION #
66737114

 

Related Articles

  • Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer. Cherkasova, E; Malinzak, E; Rao, S; Takahashi, Y; Senchenko, V N; Kudryavtseva, A V; Nickerson, M L; Merino, M; Hong, J A; Schrump, D S; Srinivasan, R; Linehan, W M; Tian, X; Lerman, M I; Childs, R W // Oncogene;11/24/2011, Vol. 30 Issue 47, p4697 

    A human endogenous retrovirus type E (HERV-E) was recently found to be selectively expressed in most renal cell carcinomas (RCCs). Importantly, antigens derived from this provirus are immunogenic, stimulating cytotoxic T cells that kill RCC cells in vitro and in vivo. Here, we show HERV-E...

  • von Hippel-Lindau disease: A clinical and scientific review. Maher, Eamonn R; Neumann, Hartmut PH; Richard, Stéphane // European Journal of Human Genetics;Jun2011, Vol. 19 Issue 6, p617 

    The autosomal dominantly inherited disorder von Hippel-Lindau disease (VHL) is caused by germline mutations in the VHL tumour suppressor gene (TSG). VHL mutations predispose to the development of a variety of tumours (most commonly retinal and central nervous system haemangioblastomas, clear...

  • Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer. Vanharanta, Sakari; Shu, Weiping; Brenet, Fabienne; Hakimi, A Ari; Heguy, Adriana; Viale, Agnes; Reuter, Victor E; Hsieh, James J-D; Scandura, Joseph M; Massagué, Joan // Nature Medicine;Jan2013, Vol. 19 Issue 1, p50 

    Inactivation of the von Hippel-Lindau tumor suppressor gene, VHL, is an archetypical tumor-initiating event in clear cell renal carcinoma (ccRCC) that leads to the activation of hypoxia-inducible transcription factors (HIFs). However, VHL mutation status in ccRCC is not correlated with clinical...

  • Epigenetic regulation of HIF-1α in renal cancer cells involves HIF-1α/2α binding to a reverse hypoxia-response element. Xu, J; Wang, B; Xu, Y; Sun, L; Tian, W; Shukla, D; Barod, R; Grillari, J; Grillari-Voglauer, R; Maxwell, P H; Esteban, M A // Oncogene;2/23/2012, Vol. 31 Issue 8, p1065 

    Inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene underlies the majority of sporadic clear cell renal cell carcinomas (CCRCCs) and is also responsible for the hereditary VHL cancer syndrome. VHL loss of function results in constitutive stabilization of hypoxia-inducible factors...

  • Localization of point mutations in the coding part of the VHL gene in clear cell renal cancer. Mikhailenko, D.; Grigor'eva, M.; Rusakov, I.; Kurynin, R.; Popov, A.; Peters, M.; Matveev, V.; Yakovleva, E.; Nosov, D.; Lyubchenko, L.; Tulyandin, S.; Strel'nikov, V.; Zaletaev, D. // Molecular Biology;Feb2012, Vol. 46 Issue 1, p65 

    The VHL gene is often inactivated in sporadic clear cell renal cancer (CCRC) due to somatic mutations, and its germline mutations cause hereditary CCRC: von Hippel-Lindau syndrome. Localization of mutations in VHL, identification of new mutations, and their influence on CCRC progression and...

  • Targeting the Genetic Basis of Kidney Cancer. Linehan, W. Marston // AUANews;Apr2013, Vol. 18 Issue 4, p22 

    The article presents several known genes that cause kidney cancer. The von Hippel-Lindau (VHL) Gene was discovered by a study of families with the inherited form of clear cell kidney cancer associated with the VHL syndrome. The MET Gene, a Type 1 papillary kidney cancer affects individuals with...

  • Von Hippel-Lindau Disease-A Case Report and Review of Literature. Reddy, Vedamurthy Pogula; Satya Rambabu, Dandu Venkata; Vaddi, Surya Prakash; Subramanian, S. // UroToday International Journal;Oct2011, Vol. 4 Issue 5, p1 

    Von Hippel-Lindau disease is a dominantly inherited familial cancer syndrome with variable expression. Here we are reporting a case of von Hippel-Lindau disease in a family.

  • Multicystic Renal Cell Carcinoma A Rare kidney Tumor in Children. Atilgan, Dogan; Uluocak, Nihat; Erdemir, Fikret; Suha Parlaktas, Bekir; Dogan Koseoglu, Resit; Boztepe, Ozgur // Urology Journal;Winter2013, Vol. 10 Issue 1, p811 

    The article presents a case study of a 14-year-old male patient with abdominal pain, flank, abdominal mass, and macroscopic hematuria. It describes the patient's condition whose medical history was normal and had no diseases that are related to tuberous sclerosis or von Hippel-Lindau disease. It...

  • Inactivation of the von Hippel-Lindau tumour suppressor gene induces Neuromedin U expression in renal cancer cells.  // Molecular Cancer;2011, Vol. 10 Issue 1, p89 

    The article offers information on the influence of inactive von Hippel-Lindau (VHL) tumour suppressor gene on Neuromedin U (NMU) expression in renal cancer cells (RCC). It states that the effect of inactive VHL is considered by activation of Hypoxia Inducible Factor (HIF) and VHL expressing RCC...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics